Cargando…
How Stable Ischemic Heart Disease Leads to Acute Coronary Syndrome in COVID-19?
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, the increased mortality risk of patients with underlying cardiovascular diseases and COVID-19 was raised. Besides, coronavirus itself enhances the incidence of myocardial injury, which suggests a two-sided relation. We aimed to...
Autores principales: | Shafeghat, Melika, Aminorroaya, Arya, Rezaei, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689303/ https://www.ncbi.nlm.nih.gov/pubmed/34738559 http://dx.doi.org/10.23750/abm.v92i5.12013 |
Ejemplares similares
-
Delta Variant: The New Challenge of COVID-19 Pandemic, an Overview of Epidemiological, Clinical, and Immune Characteristics
por: Rashedi, Ronak, et al.
Publicado: (2022) -
Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality
por: Moradian, Negar, et al.
Publicado: (2021) -
Evaluating COVID-19–Environment Fit
por: Saghazadeh, Amene, et al.
Publicado: (2022) -
Potential Prophylactic and Therapeutic Effects of Respiratory Physiotherapy for COVID-19
por: Shakerian, Narges, et al.
Publicado: (2021) -
Cognitive Biases Affecting the Maintenance of COVID-19 Pandemic
por: Mohamed, Kawthar, et al.
Publicado: (2021)